Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma.
Childs Nerv Syst
; 29(8): 1253-62, 2013 Aug.
Article
in En
| MEDLINE
| ID: mdl-23677175
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gene Expression Regulation, Neoplastic
/
Cerebellar Neoplasms
/
Receptors, Somatostatin
/
Medulloblastoma
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Childs Nerv Syst
Journal subject:
NEUROLOGIA
/
PEDIATRIA
Year:
2013
Document type:
Article
Affiliation country:
Canada
Country of publication:
Germany